What is the Ottawa Heart Failure Risk Score?
The Ottawa Heart Failure Risk Score (OHFRS) is a 10-element clinical decision tool developed to identify emergency department patients with acute heart failure who are at high risk for serious adverse events within 14-30 days, helping clinicians make safer disposition decisions about admission versus discharge.
Purpose and Development
The OHFRS was specifically created to address a critical gap in emergency medicine: many heart failure patients are discharged home from the ED and subsequently suffer serious adverse events or death 1. The tool emerged from recognition that clinical judgment alone often overestimates risk and leads to over-utilization of hospital resources, while simultaneously missing high-risk patients who get discharged 2.
Clinical Application
The OHFRS consists of 10 standardized clinical and laboratory variables that stratify patients into risk categories, with scores ranging from risk levels associated with 2.8% to 89.0% probability of serious adverse events 1. The tool demonstrated excellent accuracy in prospective validation, with sensitivity of 91.8% when using an admission threshold score >1, compared to only 71.8% sensitivity with usual clinical practice 3.
Key Performance Characteristics:
- With clinical variables alone: Using a threshold score >1 achieves 91.8% sensitivity for detecting patients who will experience serious adverse events 3
- With NT-proBNP added: Sensitivity increases further to 95.8% when quantitative NT-proBNP values are incorporated 3
- Serious adverse events are defined as: death within 30 days, admission to monitored unit, intubation, noninvasive ventilation, myocardial infarction, or relapse requiring hospital admission within 14 days 3
Clinical Context and Limitations
The OHFRS addresses a significant clinical problem: in the original derivation study, 47.7% of serious adverse events occurred in patients who were not initially admitted 1. However, using OHFRS increases admission rates (from 57.2% to 77.6% with score >1 threshold) in exchange for dramatically improved sensitivity 3. This trade-off must be weighed against the consequences of missed high-risk patients.
Recent comparative studies show that OHFRS demonstrates moderate accuracy for predicting 30-day mortality (AUC 0.706-0.774) and is superior for predicting ICU admission and hospital admission needs 4. The tool performs best when integrated with other clinical factors including symptom trajectory, hemodynamics, and access to follow-up care, rather than used in isolation 5.
Important Caveats:
- Physician acceptance was high, with discomfort reported in only 11.9% of cases 3
- The tool is most useful for identifying low-risk patients who can be safely discharged, rather than precisely predicting which admitted patients will deteriorate 6
- OHFRS does not reliably predict ED revisits 4
- The Canadian guidelines reference this as "a decision model from Canada" that can assist with early differentiation of patients requiring admission 2
Practical Implementation
With adequate physician training, OHFRS should help standardize admission practices, diminishing both unnecessary admissions for low-risk patients and unsafe discharge decisions for high-risk patients 3. The tool is particularly valuable in the context that approximately 80% of acute heart failure patients are admitted from the ED, though up to 50% could potentially be safely discharged after brief observation 2.
When NT-proBNP is available, incorporate it into the risk assessment as it significantly enhances the tool's sensitivity 3. For patients scoring >1, strong consideration for admission is warranted given the high sensitivity for capturing those who will experience serious adverse events.